Ilyang Pharmaceutical Co Ltd (007575) — Capital Reinvestment Ratio
Ilyang Pharmaceutical Co Ltd (007575) has a Capital Reinvestment Ratio of 1.47x as of June 2025, meaning it reinvests 1% of its operating cash flow (₩2.26 Billion) in capital expenditures (₩3.32 Billion). See Ilyang Pharmaceutical Co Ltd (007575) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ilyang Pharmaceutical Co Ltd Capital Reinvestment Ratio (2014–2024)
This chart tracks Ilyang Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Check how aggressively does Ilyang Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Ilyang Pharmaceutical Co Ltd (2014–2024)
Year-by-year Capital Reinvestment Ratio for Ilyang Pharmaceutical Co Ltd from 2014 to 2024. For live market cap and broader valuation context, see 007575 market cap overview.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 7.23x | ₩5.61 Billion | ₩40.62 Billion | ▲ +1448.0% |
| 2023 | 0.47x | ₩14.62 Billion | ₩6.83 Billion | ▲ +242.8% |
| 2022 | 0.14x | ₩29.94 Billion | ₩4.08 Billion | ▼ -29.2% |
| 2021 | 0.19x | ₩67.02 Billion | ₩12.91 Billion | ▲ +8.8% |
| 2020 | 0.18x | ₩57.48 Billion | ₩10.17 Billion | ▲ +194.7% |
| 2019 | 0.06x | ₩36.19 Billion | ₩2.17 Billion | ▼ -14.1% |
| 2018 | 0.07x | ₩22.12 Billion | ₩1.55 Billion | ▼ -44.5% |
| 2017 | 0.13x | ₩30.03 Billion | ₩3.78 Billion | ▼ -67.0% |
| 2016 | 0.38x | ₩26.98 Billion | ₩10.31 Billion | ▼ -4.3% |
| 2015 | 0.40x | ₩40.27 Billion | ₩16.07 Billion | ▼ -46.5% |
| 2014 | 0.75x | ₩18.63 Billion | ₩13.89 Billion | — |